Cargando…

Stress biomarkers in adult patients with drug‐resistant epilepsy on a modified Atkins diet: A prospective study

OBJECTIVE: Ketogenic diets like the modified Atkins diet (MAD) are increasingly used in patients with refractory epilepsy. For epilepsy patients, stress is a well‐known seizure‐precipitating factor. New possibilities for measuring biomarkers of stress are now available. The purpose of this study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Molteberg, Ellen, Thorsby, Per M, Kverneland, Magnhild, Iversen, Per Ole, Selmer, Kaja K, Hofoss, Dag, Nakken, Karl O, Taubøll, Erik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690645/
https://www.ncbi.nlm.nih.gov/pubmed/37574592
http://dx.doi.org/10.1002/epi4.12808
_version_ 1785152565808201728
author Molteberg, Ellen
Thorsby, Per M
Kverneland, Magnhild
Iversen, Per Ole
Selmer, Kaja K
Hofoss, Dag
Nakken, Karl O
Taubøll, Erik
author_facet Molteberg, Ellen
Thorsby, Per M
Kverneland, Magnhild
Iversen, Per Ole
Selmer, Kaja K
Hofoss, Dag
Nakken, Karl O
Taubøll, Erik
author_sort Molteberg, Ellen
collection PubMed
description OBJECTIVE: Ketogenic diets like the modified Atkins diet (MAD) are increasingly used in patients with refractory epilepsy. For epilepsy patients, stress is a well‐known seizure‐precipitating factor. New possibilities for measuring biomarkers of stress are now available. The purpose of this study was to investigate the impact of MAD on endocrine stress biomarkers. METHODS: Forty‐nine patients with drug‐resistant epilepsy were investigated at baseline and after 12 weeks on MAD. Cortisol and cortisol‐binding globulin (CBG) were measured and free cortisol index (FCI) calculated. We also measured metanephrine, normetanephrine, and methoxytyramine, all markers of epinephrine, norepinephrine, and dopamine, respectively. Changes were analyzed according to sex and antiseizure medications. The different markers at baseline and after 12 weeks of MAD treatment were correlated with seizure frequency and weight loss, respectively. RESULTS: The change in total cortisol was modest after 12 weeks on the diet (from 432.9 nmol/L (403.1–462.7)) to 422.6 nmol/L (384.6–461.0), P = 0.6). FCI was reduced (from 0.39 (0.36–0.42) to 0.34 (0.31–0.36), P = 0.001). CBG increased during the study (from 1126.4 nmol/L (1074.5–1178.3) to 1272.5 nmol/L (1206.3–1338.7), P < 0.001). There were no changes in the metanephrines after 12 weeks on the diet. The decrease in FCI was significant only in women, and only observed in patients using nonenzyme‐inducing ASMs. We did not find any correlation between cortisol, CBG, or FCI levels and seizure frequency. SIGNIFICANCE: After being on MAD for 12 weeks, FCI decreased significantly. The reduction in FCI may reflect reduced stress, but it may also be an effect of increased CBG. The reasons behind these alterations are unknown. Possibly, the changes may be a result of a reduction in insulin resistance and thyroid hormone levels. Treatment with MAD does not seem to influence “fight or flight” hormones.
format Online
Article
Text
id pubmed-10690645
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-106906452023-12-02 Stress biomarkers in adult patients with drug‐resistant epilepsy on a modified Atkins diet: A prospective study Molteberg, Ellen Thorsby, Per M Kverneland, Magnhild Iversen, Per Ole Selmer, Kaja K Hofoss, Dag Nakken, Karl O Taubøll, Erik Epilepsia Open Original Articles OBJECTIVE: Ketogenic diets like the modified Atkins diet (MAD) are increasingly used in patients with refractory epilepsy. For epilepsy patients, stress is a well‐known seizure‐precipitating factor. New possibilities for measuring biomarkers of stress are now available. The purpose of this study was to investigate the impact of MAD on endocrine stress biomarkers. METHODS: Forty‐nine patients with drug‐resistant epilepsy were investigated at baseline and after 12 weeks on MAD. Cortisol and cortisol‐binding globulin (CBG) were measured and free cortisol index (FCI) calculated. We also measured metanephrine, normetanephrine, and methoxytyramine, all markers of epinephrine, norepinephrine, and dopamine, respectively. Changes were analyzed according to sex and antiseizure medications. The different markers at baseline and after 12 weeks of MAD treatment were correlated with seizure frequency and weight loss, respectively. RESULTS: The change in total cortisol was modest after 12 weeks on the diet (from 432.9 nmol/L (403.1–462.7)) to 422.6 nmol/L (384.6–461.0), P = 0.6). FCI was reduced (from 0.39 (0.36–0.42) to 0.34 (0.31–0.36), P = 0.001). CBG increased during the study (from 1126.4 nmol/L (1074.5–1178.3) to 1272.5 nmol/L (1206.3–1338.7), P < 0.001). There were no changes in the metanephrines after 12 weeks on the diet. The decrease in FCI was significant only in women, and only observed in patients using nonenzyme‐inducing ASMs. We did not find any correlation between cortisol, CBG, or FCI levels and seizure frequency. SIGNIFICANCE: After being on MAD for 12 weeks, FCI decreased significantly. The reduction in FCI may reflect reduced stress, but it may also be an effect of increased CBG. The reasons behind these alterations are unknown. Possibly, the changes may be a result of a reduction in insulin resistance and thyroid hormone levels. Treatment with MAD does not seem to influence “fight or flight” hormones. John Wiley and Sons Inc. 2023-09-13 /pmc/articles/PMC10690645/ /pubmed/37574592 http://dx.doi.org/10.1002/epi4.12808 Text en © 2023 The Authors. Epilepsia Open published by Wiley Periodicals LLC on behalf of International League Against Epilepsy. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Molteberg, Ellen
Thorsby, Per M
Kverneland, Magnhild
Iversen, Per Ole
Selmer, Kaja K
Hofoss, Dag
Nakken, Karl O
Taubøll, Erik
Stress biomarkers in adult patients with drug‐resistant epilepsy on a modified Atkins diet: A prospective study
title Stress biomarkers in adult patients with drug‐resistant epilepsy on a modified Atkins diet: A prospective study
title_full Stress biomarkers in adult patients with drug‐resistant epilepsy on a modified Atkins diet: A prospective study
title_fullStr Stress biomarkers in adult patients with drug‐resistant epilepsy on a modified Atkins diet: A prospective study
title_full_unstemmed Stress biomarkers in adult patients with drug‐resistant epilepsy on a modified Atkins diet: A prospective study
title_short Stress biomarkers in adult patients with drug‐resistant epilepsy on a modified Atkins diet: A prospective study
title_sort stress biomarkers in adult patients with drug‐resistant epilepsy on a modified atkins diet: a prospective study
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690645/
https://www.ncbi.nlm.nih.gov/pubmed/37574592
http://dx.doi.org/10.1002/epi4.12808
work_keys_str_mv AT moltebergellen stressbiomarkersinadultpatientswithdrugresistantepilepsyonamodifiedatkinsdietaprospectivestudy
AT thorsbyperm stressbiomarkersinadultpatientswithdrugresistantepilepsyonamodifiedatkinsdietaprospectivestudy
AT kvernelandmagnhild stressbiomarkersinadultpatientswithdrugresistantepilepsyonamodifiedatkinsdietaprospectivestudy
AT iversenperole stressbiomarkersinadultpatientswithdrugresistantepilepsyonamodifiedatkinsdietaprospectivestudy
AT selmerkajak stressbiomarkersinadultpatientswithdrugresistantepilepsyonamodifiedatkinsdietaprospectivestudy
AT hofossdag stressbiomarkersinadultpatientswithdrugresistantepilepsyonamodifiedatkinsdietaprospectivestudy
AT nakkenkarlo stressbiomarkersinadultpatientswithdrugresistantepilepsyonamodifiedatkinsdietaprospectivestudy
AT taubøllerik stressbiomarkersinadultpatientswithdrugresistantepilepsyonamodifiedatkinsdietaprospectivestudy